Hepatitis B reactivation: reducing the risk in patients with inflammatory bowel disease
dc.contributor.author | Dolman, GE | en_US |
dc.contributor.author | Kennedy, PTF | en_US |
dc.date.accessioned | 2022-09-08T10:19:44Z | |
dc.date.available | 2020-01-22 | en_US |
dc.date.issued | 2020 | en_US |
dc.identifier.issn | 0017-5749 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/80366 | |
dc.format.extent | 2053 - + | en_US |
dc.relation.ispartof | GUT | en_US |
dc.title | Hepatitis B reactivation: reducing the risk in patients with inflammatory bowel disease | en_US |
dc.type | Article | |
dc.identifier.doi | 10.1136/gutjnl-2019-319480 | en_US |
pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000582822600023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 11 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 69 | en_US |
Files in this item
This item appears in the following Collection(s)
-
Centre for Immunobiology [1121]